We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
+62.54%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
Cap. Flow
+$123M
Cap. Flow %
85.23%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 30.21%
2 Healthcare 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRAY
1
DELISTED
ViewRay, Inc.
VRAY
$63.4M 43.76%
+6,842,975
New +$54.8M
CHRN
2
ChronoScale Holdings
CHRN
$3.12B
$43.7M 30.21%
+91,266
New +$38.1M
BLPH
3
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$21.4M 14.79%
+553,250
New +$14.5M
KDMN
4
DELISTED
Kadmon Holdings, Inc.
KDMN
$16.3M 11.25%
+4,500,000
New +$16.1M

Similar funds

Puissance Capital Management's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for Puissance Capital Management, which disclosed 4 positions worth $145M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is ViewRay, Inc.: 6,842,975 shares worth $63.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, followed by Healthcare.

  • Puissance Capital Management's largest Q4 2017 buy was ViewRay, Inc.: 6,842,975 shares worth $63.4M.
  • Puissance Capital Management's ten largest holdings make up 100% of its $145M portfolio in Q4 2017.
  • Puissance Capital Management disclosed 4 positions in Q4 2017, its first 13F filing on record.

Based on Puissance Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.